Use of a fatty acid composition comprising at least one of EPA and DHA or any combinations thereof
A method is disclosed for treatment and prevention of obesity, an overweight condition or for controlling body weight reduction, wherein an effective amount of a fatty acid composition comprising at least one of (all-Z omega-3)-5,8,11,14,17-eicosapentaenoic acid (EPA) and (all-Z omega-3)-4,7,10,13,16,19-docosahexaenoic acid (DHA) or any combinations thereof, is administered to a human or an animal. Additionally, a dietary product is disclosed, containing a fatty acid composition comprising at least one of EPA and DHA or any combinations thereof, for non-medical treatment of obesity, an overweight condition and/or for supporting and controlling body weight reduction. Finally, a method is disclosed for supplementing a dietary product with a fatty acid composition mentioned above.
1. A method for at least one of treatment of obesity, prevention of obesity, treatment of an overweight condition, prevention of an overweight condition, controlling body weight reduction, and prevention of body weight gain, comprising:
administering an effective amount of a fatty acid composition comprising at least one of (all-Z omega-3)-5,8,11,14,17-eicosapentaenoic acid (EPA), or derivatives thereof, and (all-Z omega-3)-4,7,10,13,16,19-docosahexaenoic acid (DHA), or derivatives thereof, or any combinations thereof, to at least one of a human and an animal, wherein the weight ratio of EPA:DHA in the fatty acid composition is 1:X, where X is greater than 1;
wherein the concentration of EPA ranges from 10% to 20% and the concentration of DHA ranges from 20% to 50%;
wherein the human is an adult.
2. The method according to claim 1 , wherein the EPA and DHA are present in the composition in an EPA:DHA ratio ranging no more than 1:8.
3. The method according to claim 1 , wherein the fatty acids in the composition are present in at least one of esterified form, ethyl ester form, salt form and free acid form, and any combinations thereof.
4. The method according to claim 1 , wherein the fatty acid composition comprises EPA and DHA in triglyceride form.
5. The method according to claim 1 , wherein at least one of EPA and DHA is obtained from at least one of vegetable, microbial and animal origin.
6. The method according to claim 1 , wherein at least a part of the EPA and/or DHA is obtained from a marine oil.
7. The method according to claim 1 , wherein the composition is administered orally to the at least one of a human and an animal.
8. The method according to claim 1 , wherein the treatment is carried out together with a reduced intake of calories for the at least one of a human and an animal.
9. The method according to claim 1 , wherein said fatty acid composition is administered in a daily dosage that corresponds to at least 10% of the total lipid content of a daily diet for the at least one of a human and an animal.
10. A method for supplementing a dietary product comprising:
adding a fatty acid composition comprising at least one of (all-Z omega-3)5,8,11,14,17-eicosapentaenoic acid (EPA), or derivatives thereof, and (all-Z omega-3)4,7,10,13,16,19-docosahexaenoic acid (DHA), or derivatives thereof, or any combinations thereof, to supplement the dietary product for at least one of prevention of body weight gain and controlling and supporting weight reduction in a human, wherein the weight ratio of EPA:DHA in the fatty add composition is 1:X, where X is larger than 1;
wherein the concentration of EPA ranges from 10% to 20% and the concentration of DHA ranges from 20% to 50%;
wherein the human is an adult.
11. The method according to claim 10 , wherein the fatty acid composition is present in at least one of liquid form and as an emulsion, being incorporated in said dietary product.
12. The method according to claim 10 , wherein said fatty acid composition is chosen from a supplement, a food supplement, and a nutritional product.
13. A method for at least one of treatment of obesity, prevention of obesity, treatment of an overweight condition, prevention of an overweight condition, controlling body weight reduction, and prevention of body weight gain, comprising:
administering an effective amount of a fatty acid composition comprising at least one of (all-Z omega-3)-5,8,11,14,17-eicosapentaenoic acid (EPA), or derivatives thereof, and (all-Z omega-3)-4,7,10,13,16,19-docosahexaenoic acid (DHA), or derivatives thereof, or any combinations thereof, to at least one of a human and an animal, wherein the concentration of EPA ranges from 10% to 20% and the concentration of DHA ranges from 20% to 50% and the concentration of DHA is greater than the concentration of EPA;
wherein the human is an adult.
14. The method according to claim 13 , wherein the concentration of EPA is 10% and the concentration of DHA is 50%.
15. The method according to claim 13 , wherein the concentration of EPA is 20% and the concentration of DHA is 50%.
16. The method according to claim 1 , wherein the concentration of EP is 10% and the concentration of DHA is 50%.
17. The method according to claim 1 , wherein the concentration of EPA is 20% and the concentration of DHA is 50%.
18. The method according to claim 10 , wherein the concentration of EP is 10% and the concentration of DHA is 50%.
19. The method according to claim 10 , wherein the concentration of EPA is 20% and the concentration of DHA is 50%.